Aaron Tward

Aaron Tward M.D. Ph.D. is Chief Scientific Officer at Akouos. He brings to Akouos more than fifteen years of experience in Otology. He is a surgeon-scientist and pioneer in the application of high-throughput sequencing technologies to critical problems in biomedicine. Dr. Tward serves as an Associate Professor at UCSF and is a co-founder of Affinia Therapeutics Dr. Tward has authored more than 30 publications spanning the fields of genomics, cancer biology, stem cell biology, and skull base surgery. He received both a Ph.D. in biomedical sciences and an M.D. from UCSF and completed his residency in otolaryngology-head and neck surgery and fellowship in otology, neurotology, and skull base surgery at Harvard Medical School. He completed a post-doctoral fellowship at the Broad Institute of MIT and Harvard.